nodes	percent_of_prediction	percent_of_DWPC	metapath
Adenosine triphosphate—Regadenoson—Cladribine—multiple sclerosis	0.106	0.164	CrCrCtD
Adenosine triphosphate—Fludarabine—Cladribine—multiple sclerosis	0.0999	0.154	CrCrCtD
Adenosine triphosphate—Nelarabine—Cladribine—multiple sclerosis	0.0941	0.145	CrCrCtD
Adenosine triphosphate—Adenosine monophosphate—Cladribine—multiple sclerosis	0.0941	0.145	CrCrCtD
Adenosine triphosphate—Vidarabine—Cladribine—multiple sclerosis	0.0846	0.13	CrCrCtD
Adenosine triphosphate—Azacitidine—Cladribine—multiple sclerosis	0.0846	0.13	CrCrCtD
Adenosine triphosphate—Adenosine—Cladribine—multiple sclerosis	0.0846	0.13	CrCrCtD
Adenosine triphosphate—ABCB11—Dexamethasone—multiple sclerosis	0.0233	0.256	CbGbCtD
Adenosine triphosphate—ABCC2—Dexamethasone—multiple sclerosis	0.0123	0.135	CbGbCtD
Adenosine triphosphate—ABCB1—Methylprednisolone—multiple sclerosis	0.0106	0.116	CbGbCtD
Adenosine triphosphate—ABCC2—Methotrexate—multiple sclerosis	0.00985	0.108	CbGbCtD
Adenosine triphosphate—ABCB1—Mitoxantrone—multiple sclerosis	0.00771	0.0847	CbGbCtD
Adenosine triphosphate—ABCB1—Betamethasone—multiple sclerosis	0.00687	0.0755	CbGbCtD
Adenosine triphosphate—ABCB1—Prednisolone—multiple sclerosis	0.00678	0.0745	CbGbCtD
Adenosine triphosphate—ABCB1—Prednisone—multiple sclerosis	0.0064	0.0704	CbGbCtD
Adenosine triphosphate—ABCB1—Dexamethasone—multiple sclerosis	0.00399	0.0439	CbGbCtD
Adenosine triphosphate—S-Adenosylmethionine—SRM—multiple sclerosis	0.00345	0.707	CrCbGaD
Adenosine triphosphate—ABCB1—Methotrexate—multiple sclerosis	0.00321	0.0353	CbGbCtD
Adenosine triphosphate—AKT1—leg—multiple sclerosis	0.00286	0.0268	CbGeAlD
Adenosine triphosphate—SLC25A4—peripheral nervous system—multiple sclerosis	0.00273	0.0256	CbGeAlD
Adenosine triphosphate—ADRBK1—peripheral nervous system—multiple sclerosis	0.00242	0.0227	CbGeAlD
Adenosine triphosphate—AKT1—nerve—multiple sclerosis	0.00155	0.0145	CbGeAlD
Adenosine triphosphate—Fludarabine—RRM1—multiple sclerosis	0.00143	0.293	CrCbGaD
Adenosine triphosphate—ADCY1—brainstem—multiple sclerosis	0.0012	0.0113	CbGeAlD
Adenosine triphosphate—ABCG1—retina—multiple sclerosis	0.0012	0.0112	CbGeAlD
Adenosine triphosphate—ADCY1—retina—multiple sclerosis	0.00116	0.0109	CbGeAlD
Adenosine triphosphate—CDK15—nervous system—multiple sclerosis	0.00115	0.0107	CbGeAlD
Adenosine triphosphate—CDK15—central nervous system—multiple sclerosis	0.0011	0.0103	CbGeAlD
Adenosine triphosphate—ARAF—retina—multiple sclerosis	0.00105	0.00981	CbGeAlD
Adenosine triphosphate—ASNA1—brainstem—multiple sclerosis	0.00102	0.00954	CbGeAlD
Adenosine triphosphate—AFG3L2—brainstem—multiple sclerosis	0.001	0.00942	CbGeAlD
Adenosine triphosphate—NAE1—brainstem—multiple sclerosis	0.00098	0.00919	CbGeAlD
Adenosine triphosphate—AFG3L2—retina—multiple sclerosis	0.000969	0.00908	CbGeAlD
Adenosine triphosphate—APAF1—cerebellum—multiple sclerosis	0.000961	0.00901	CbGeAlD
Adenosine triphosphate—ADRBK2—medulla oblongata—multiple sclerosis	0.000955	0.00896	CbGeAlD
Adenosine triphosphate—NAE1—retina—multiple sclerosis	0.000945	0.00886	CbGeAlD
Adenosine triphosphate—SLC25A4—retina—multiple sclerosis	0.00088	0.00826	CbGeAlD
Adenosine triphosphate—CDK15—brain—multiple sclerosis	0.000876	0.00821	CbGeAlD
Adenosine triphosphate—ABCG1—medulla oblongata—multiple sclerosis	0.000866	0.00812	CbGeAlD
Adenosine triphosphate—HSPA1A—medulla oblongata—multiple sclerosis	0.000808	0.00758	CbGeAlD
Adenosine triphosphate—HSPA1B—medulla oblongata—multiple sclerosis	0.000808	0.00758	CbGeAlD
Adenosine triphosphate—ABCG1—midbrain—multiple sclerosis	0.000792	0.00743	CbGeAlD
Adenosine triphosphate—APAF1—brain—multiple sclerosis	0.000781	0.00732	CbGeAlD
Adenosine triphosphate—ABCG1—spinal cord—multiple sclerosis	0.000772	0.00724	CbGeAlD
Adenosine triphosphate—ACVR1—retina—multiple sclerosis	0.000764	0.00717	CbGeAlD
Adenosine triphosphate—ARAF—medulla oblongata—multiple sclerosis	0.000756	0.00709	CbGeAlD
Adenosine triphosphate—HSPA1B—midbrain—multiple sclerosis	0.000739	0.00693	CbGeAlD
Adenosine triphosphate—HSPA1A—midbrain—multiple sclerosis	0.000739	0.00693	CbGeAlD
Adenosine triphosphate—HSPA1A—spinal cord—multiple sclerosis	0.000721	0.00676	CbGeAlD
Adenosine triphosphate—HSPA1B—spinal cord—multiple sclerosis	0.000721	0.00676	CbGeAlD
Adenosine triphosphate—ADRBK2—nervous system—multiple sclerosis	0.000718	0.00673	CbGeAlD
Adenosine triphosphate—ASNA1—medulla oblongata—multiple sclerosis	0.000709	0.00665	CbGeAlD
Adenosine triphosphate—AFG3L2—medulla oblongata—multiple sclerosis	0.0007	0.00657	CbGeAlD
Adenosine triphosphate—ARAF—midbrain—multiple sclerosis	0.000691	0.00648	CbGeAlD
Adenosine triphosphate—ADRBK2—central nervous system—multiple sclerosis	0.000691	0.00648	CbGeAlD
Adenosine triphosphate—NAE1—medulla oblongata—multiple sclerosis	0.000683	0.00641	CbGeAlD
Adenosine triphosphate—ADRBK2—cerebellum—multiple sclerosis	0.000675	0.00633	CbGeAlD
Adenosine triphosphate—ARAF—spinal cord—multiple sclerosis	0.000674	0.00632	CbGeAlD
Adenosine triphosphate—AKT1—brainstem—multiple sclerosis	0.000666	0.00624	CbGeAlD
Adenosine triphosphate—ACVRL1—nervous system—multiple sclerosis	0.000651	0.0061	CbGeAlD
Adenosine triphosphate—ALK—medulla oblongata—multiple sclerosis	0.00065	0.00609	CbGeAlD
Adenosine triphosphate—ASNA1—midbrain—multiple sclerosis	0.000648	0.00608	CbGeAlD
Adenosine triphosphate—AKT1—retina—multiple sclerosis	0.000642	0.00602	CbGeAlD
Adenosine triphosphate—AFG3L2—midbrain—multiple sclerosis	0.00064	0.006	CbGeAlD
Adenosine triphosphate—SLC25A4—medulla oblongata—multiple sclerosis	0.000636	0.00597	CbGeAlD
Adenosine triphosphate—ASNA1—spinal cord—multiple sclerosis	0.000632	0.00593	CbGeAlD
Adenosine triphosphate—ADCY1—nervous system—multiple sclerosis	0.000631	0.00592	CbGeAlD
Adenosine triphosphate—ACVRL1—central nervous system—multiple sclerosis	0.000627	0.00588	CbGeAlD
Adenosine triphosphate—NAE1—midbrain—multiple sclerosis	0.000624	0.00586	CbGeAlD
Adenosine triphosphate—AFG3L2—spinal cord—multiple sclerosis	0.000624	0.00586	CbGeAlD
Adenosine triphosphate—ABCG1—cerebellum—multiple sclerosis	0.000613	0.00574	CbGeAlD
Adenosine triphosphate—ACVRL1—cerebellum—multiple sclerosis	0.000613	0.00574	CbGeAlD
Adenosine triphosphate—NAE1—spinal cord—multiple sclerosis	0.000609	0.00571	CbGeAlD
Adenosine triphosphate—ADCY1—central nervous system—multiple sclerosis	0.000607	0.0057	CbGeAlD
Adenosine triphosphate—ADCY1—cerebellum—multiple sclerosis	0.000594	0.00557	CbGeAlD
Adenosine triphosphate—ALK—midbrain—multiple sclerosis	0.000594	0.00557	CbGeAlD
Adenosine triphosphate—SLC25A4—midbrain—multiple sclerosis	0.000582	0.00545	CbGeAlD
Adenosine triphosphate—HSPA1B—cerebellum—multiple sclerosis	0.000572	0.00536	CbGeAlD
Adenosine triphosphate—HSPA1A—cerebellum—multiple sclerosis	0.000572	0.00536	CbGeAlD
Adenosine triphosphate—ARAF—nervous system—multiple sclerosis	0.000568	0.00533	CbGeAlD
Adenosine triphosphate—SLC25A4—spinal cord—multiple sclerosis	0.000567	0.00532	CbGeAlD
Adenosine triphosphate—ACSS1—medulla oblongata—multiple sclerosis	0.000564	0.00529	CbGeAlD
Adenosine triphosphate—ACVR1—medulla oblongata—multiple sclerosis	0.000552	0.00518	CbGeAlD
Adenosine triphosphate—NT5C2—medulla oblongata—multiple sclerosis	0.000552	0.00518	CbGeAlD
Adenosine triphosphate—ACVR1B—nervous system—multiple sclerosis	0.000551	0.00517	CbGeAlD
Adenosine triphosphate—ADRBK2—brain—multiple sclerosis	0.000548	0.00514	CbGeAlD
Adenosine triphosphate—ARAF—central nervous system—multiple sclerosis	0.000547	0.00513	CbGeAlD
Adenosine triphosphate—ACSS2—medulla oblongata—multiple sclerosis	0.000541	0.00507	CbGeAlD
Adenosine triphosphate—ACSL1—medulla oblongata—multiple sclerosis	0.000538	0.00504	CbGeAlD
Adenosine triphosphate—ARAF—cerebellum—multiple sclerosis	0.000535	0.00501	CbGeAlD
Adenosine triphosphate—ASNA1—nervous system—multiple sclerosis	0.000533	0.005	CbGeAlD
Adenosine triphosphate—ACVR1B—central nervous system—multiple sclerosis	0.000531	0.00498	CbGeAlD
Adenosine triphosphate—AFG3L2—nervous system—multiple sclerosis	0.000526	0.00493	CbGeAlD
Adenosine triphosphate—ACVR1B—cerebellum—multiple sclerosis	0.000519	0.00487	CbGeAlD
Adenosine triphosphate—ACSS1—midbrain—multiple sclerosis	0.000516	0.00484	CbGeAlD
Adenosine triphosphate—NAE1—nervous system—multiple sclerosis	0.000513	0.00481	CbGeAlD
Adenosine triphosphate—ASNA1—central nervous system—multiple sclerosis	0.000513	0.00481	CbGeAlD
Adenosine triphosphate—AFG3L2—central nervous system—multiple sclerosis	0.000507	0.00475	CbGeAlD
Adenosine triphosphate—NT5C2—midbrain—multiple sclerosis	0.000505	0.00473	CbGeAlD
Adenosine triphosphate—ACVR1—midbrain—multiple sclerosis	0.000505	0.00473	CbGeAlD
Adenosine triphosphate—ACSS1—spinal cord—multiple sclerosis	0.000503	0.00472	CbGeAlD
Adenosine triphosphate—ASNA1—cerebellum—multiple sclerosis	0.000502	0.0047	CbGeAlD
Adenosine triphosphate—ABCA1—spinal cord—multiple sclerosis	0.000498	0.00467	CbGeAlD
Adenosine triphosphate—ACVRL1—brain—multiple sclerosis	0.000498	0.00467	CbGeAlD
Adenosine triphosphate—ABCG1—brain—multiple sclerosis	0.000498	0.00467	CbGeAlD
Adenosine triphosphate—AFG3L2—cerebellum—multiple sclerosis	0.000495	0.00464	CbGeAlD
Adenosine triphosphate—ACSS2—midbrain—multiple sclerosis	0.000495	0.00464	CbGeAlD
Adenosine triphosphate—NAE1—central nervous system—multiple sclerosis	0.000494	0.00463	CbGeAlD
Adenosine triphosphate—NT5C2—spinal cord—multiple sclerosis	0.000493	0.00462	CbGeAlD
Adenosine triphosphate—ACVR1—spinal cord—multiple sclerosis	0.000493	0.00462	CbGeAlD
Adenosine triphosphate—ACSL1—midbrain—multiple sclerosis	0.000491	0.00461	CbGeAlD
Adenosine triphosphate—ADK—retina—multiple sclerosis	0.000489	0.00459	CbGeAlD
Adenosine triphosphate—ALK—nervous system—multiple sclerosis	0.000488	0.00458	CbGeAlD
Adenosine triphosphate—NAE1—cerebellum—multiple sclerosis	0.000483	0.00453	CbGeAlD
Adenosine triphosphate—ACSS2—spinal cord—multiple sclerosis	0.000483	0.00452	CbGeAlD
Adenosine triphosphate—ADCY1—brain—multiple sclerosis	0.000482	0.00452	CbGeAlD
Adenosine triphosphate—ACSL1—spinal cord—multiple sclerosis	0.000479	0.0045	CbGeAlD
Adenosine triphosphate—SLC25A4—nervous system—multiple sclerosis	0.000478	0.00448	CbGeAlD
Adenosine triphosphate—ABCC9—brain—multiple sclerosis	0.000473	0.00444	CbGeAlD
Adenosine triphosphate—ABCC8—brainstem—multiple sclerosis	0.00047	0.00441	CbGeAlD
Adenosine triphosphate—ALK—central nervous system—multiple sclerosis	0.00047	0.00441	CbGeAlD
Adenosine triphosphate—TNK2—nervous system—multiple sclerosis	0.000469	0.0044	CbGeAlD
Adenosine triphosphate—AKT1—medulla oblongata—multiple sclerosis	0.000464	0.00435	CbGeAlD
Adenosine triphosphate—ASNS—medulla oblongata—multiple sclerosis	0.000464	0.00435	CbGeAlD
Adenosine triphosphate—HSPA1B—brain—multiple sclerosis	0.000464	0.00435	CbGeAlD
Adenosine triphosphate—HSPA1A—brain—multiple sclerosis	0.000464	0.00435	CbGeAlD
Adenosine triphosphate—SLC25A4—central nervous system—multiple sclerosis	0.00046	0.00432	CbGeAlD
Adenosine triphosphate—TNK2—central nervous system—multiple sclerosis	0.000451	0.00423	CbGeAlD
Adenosine triphosphate—SLC25A4—cerebellum—multiple sclerosis	0.00045	0.00422	CbGeAlD
Adenosine triphosphate—TNK2—cerebellum—multiple sclerosis	0.000441	0.00414	CbGeAlD
Adenosine triphosphate—ARAF—brain—multiple sclerosis	0.000434	0.00407	CbGeAlD
Adenosine triphosphate—ASNS—midbrain—multiple sclerosis	0.000424	0.00398	CbGeAlD
Adenosine triphosphate—AKT1—midbrain—multiple sclerosis	0.000424	0.00398	CbGeAlD
Adenosine triphosphate—ADRBK1—nervous system—multiple sclerosis	0.000424	0.00398	CbGeAlD
Adenosine triphosphate—ACSS1—nervous system—multiple sclerosis	0.000424	0.00398	CbGeAlD
Adenosine triphosphate—ACVR1B—brain—multiple sclerosis	0.000422	0.00395	CbGeAlD
Adenosine triphosphate—ABCA1—nervous system—multiple sclerosis	0.000419	0.00393	CbGeAlD
Adenosine triphosphate—NT5C2—nervous system—multiple sclerosis	0.000415	0.00389	CbGeAlD
Adenosine triphosphate—ACVR1—nervous system—multiple sclerosis	0.000415	0.00389	CbGeAlD
Adenosine triphosphate—AKT1—spinal cord—multiple sclerosis	0.000414	0.00388	CbGeAlD
Adenosine triphosphate—ASNS—spinal cord—multiple sclerosis	0.000414	0.00388	CbGeAlD
Adenosine triphosphate—ADRBK1—central nervous system—multiple sclerosis	0.000408	0.00383	CbGeAlD
Adenosine triphosphate—ACSS1—central nervous system—multiple sclerosis	0.000408	0.00383	CbGeAlD
Adenosine triphosphate—ASNA1—brain—multiple sclerosis	0.000407	0.00382	CbGeAlD
Adenosine triphosphate—ACSS2—nervous system—multiple sclerosis	0.000407	0.00381	CbGeAlD
Adenosine triphosphate—ASS1—medulla oblongata—multiple sclerosis	0.000405	0.0038	CbGeAlD
Adenosine triphosphate—ACSL1—nervous system—multiple sclerosis	0.000404	0.00379	CbGeAlD
Adenosine triphosphate—ABCA1—central nervous system—multiple sclerosis	0.000404	0.00379	CbGeAlD
Adenosine triphosphate—AFG3L2—brain—multiple sclerosis	0.000402	0.00377	CbGeAlD
Adenosine triphosphate—ACVR1—central nervous system—multiple sclerosis	0.0004	0.00375	CbGeAlD
Adenosine triphosphate—NT5C2—central nervous system—multiple sclerosis	0.0004	0.00375	CbGeAlD
Adenosine triphosphate—ADRBK1—cerebellum—multiple sclerosis	0.000399	0.00374	CbGeAlD
Adenosine triphosphate—ACSS1—cerebellum—multiple sclerosis	0.000399	0.00374	CbGeAlD
Adenosine triphosphate—ABCA1—cerebellum—multiple sclerosis	0.000395	0.0037	CbGeAlD
Adenosine triphosphate—NAE1—brain—multiple sclerosis	0.000392	0.00368	CbGeAlD
Adenosine triphosphate—ACSS2—central nervous system—multiple sclerosis	0.000391	0.00367	CbGeAlD
Adenosine triphosphate—NT5C2—cerebellum—multiple sclerosis	0.000391	0.00366	CbGeAlD
Adenosine triphosphate—ACVR1—cerebellum—multiple sclerosis	0.000391	0.00366	CbGeAlD
Adenosine triphosphate—ACSL1—central nervous system—multiple sclerosis	0.000389	0.00365	CbGeAlD
Adenosine triphosphate—ACSS2—cerebellum—multiple sclerosis	0.000383	0.00359	CbGeAlD
Adenosine triphosphate—PRKAA1—nervous system—multiple sclerosis	0.000382	0.00358	CbGeAlD
Adenosine triphosphate—ACSL1—cerebellum—multiple sclerosis	0.00038	0.00356	CbGeAlD
Adenosine triphosphate—ALK—brain—multiple sclerosis	0.000373	0.0035	CbGeAlD
Adenosine triphosphate—ABL2—cerebellum—multiple sclerosis	0.000373	0.0035	CbGeAlD
Adenosine triphosphate—ASS1—midbrain—multiple sclerosis	0.00037	0.00347	CbGeAlD
Adenosine triphosphate—PRKAA1—central nervous system—multiple sclerosis	0.000368	0.00345	CbGeAlD
Adenosine triphosphate—SLC25A4—brain—multiple sclerosis	0.000365	0.00343	CbGeAlD
Adenosine triphosphate—ABL1—brainstem—multiple sclerosis	0.000365	0.00342	CbGeAlD
Adenosine triphosphate—ASS1—spinal cord—multiple sclerosis	0.000361	0.00338	CbGeAlD
Adenosine triphosphate—PRKAA1—cerebellum—multiple sclerosis	0.00036	0.00337	CbGeAlD
Adenosine triphosphate—TNK2—brain—multiple sclerosis	0.000358	0.00336	CbGeAlD
Adenosine triphosphate—ADK—medulla oblongata—multiple sclerosis	0.000353	0.00331	CbGeAlD
Adenosine triphosphate—ABL1—retina—multiple sclerosis	0.000352	0.0033	CbGeAlD
Adenosine triphosphate—AKT1—nervous system—multiple sclerosis	0.000349	0.00327	CbGeAlD
Adenosine triphosphate—AKT1—central nervous system—multiple sclerosis	0.000336	0.00315	CbGeAlD
Adenosine triphosphate—ASNS—cerebellum—multiple sclerosis	0.000328	0.00308	CbGeAlD
Adenosine triphosphate—AKT1—cerebellum—multiple sclerosis	0.000328	0.00308	CbGeAlD
Adenosine triphosphate—ABCC8—medulla oblongata—multiple sclerosis	0.000328	0.00307	CbGeAlD
Adenosine triphosphate—ADRBK1—brain—multiple sclerosis	0.000324	0.00304	CbGeAlD
Adenosine triphosphate—ACSS1—brain—multiple sclerosis	0.000324	0.00304	CbGeAlD
Adenosine triphosphate—ADK—midbrain—multiple sclerosis	0.000323	0.00303	CbGeAlD
Adenosine triphosphate—ABCA1—brain—multiple sclerosis	0.000321	0.00301	CbGeAlD
Adenosine triphosphate—NT5C2—brain—multiple sclerosis	0.000317	0.00297	CbGeAlD
Adenosine triphosphate—ACVR1—brain—multiple sclerosis	0.000317	0.00297	CbGeAlD
Adenosine triphosphate—ADK—spinal cord—multiple sclerosis	0.000315	0.00296	CbGeAlD
Adenosine triphosphate—ACSS2—brain—multiple sclerosis	0.000311	0.00291	CbGeAlD
Adenosine triphosphate—ACSL1—brain—multiple sclerosis	0.000309	0.0029	CbGeAlD
Adenosine triphosphate—ASS1—nervous system—multiple sclerosis	0.000304	0.00285	CbGeAlD
Adenosine triphosphate—ABL2—brain—multiple sclerosis	0.000303	0.00284	CbGeAlD
Adenosine triphosphate—ABCC8—midbrain—multiple sclerosis	0.0003	0.00281	CbGeAlD
Adenosine triphosphate—ASS1—central nervous system—multiple sclerosis	0.000293	0.00275	CbGeAlD
Adenosine triphosphate—ABCC8—spinal cord—multiple sclerosis	0.000292	0.00274	CbGeAlD
Adenosine triphosphate—PRKAA1—brain—multiple sclerosis	0.000292	0.00274	CbGeAlD
Adenosine triphosphate—ASS1—cerebellum—multiple sclerosis	0.000286	0.00268	CbGeAlD
Adenosine triphosphate—ASNS—brain—multiple sclerosis	0.000267	0.0025	CbGeAlD
Adenosine triphosphate—AKT1—brain—multiple sclerosis	0.000267	0.0025	CbGeAlD
Adenosine triphosphate—ADK—nervous system—multiple sclerosis	0.000266	0.00249	CbGeAlD
Adenosine triphosphate—ADK—central nervous system—multiple sclerosis	0.000256	0.0024	CbGeAlD
Adenosine triphosphate—ABL1—medulla oblongata—multiple sclerosis	0.000254	0.00239	CbGeAlD
Adenosine triphosphate—ADK—cerebellum—multiple sclerosis	0.00025	0.00234	CbGeAlD
Adenosine triphosphate—ABCC8—nervous system—multiple sclerosis	0.000246	0.00231	CbGeAlD
Adenosine triphosphate—ABCC8—central nervous system—multiple sclerosis	0.000237	0.00222	CbGeAlD
Adenosine triphosphate—ABL1—midbrain—multiple sclerosis	0.000232	0.00218	CbGeAlD
Adenosine triphosphate—ASS1—brain—multiple sclerosis	0.000232	0.00218	CbGeAlD
Adenosine triphosphate—ABCC8—cerebellum—multiple sclerosis	0.000232	0.00217	CbGeAlD
Adenosine triphosphate—ABL1—spinal cord—multiple sclerosis	0.000227	0.00213	CbGeAlD
Adenosine triphosphate—HSPA1A—Clofarabine—Cladribine—multiple sclerosis	0.000207	0.0506	CbGdCrCtD
Adenosine triphosphate—ADK—brain—multiple sclerosis	0.000203	0.0019	CbGeAlD
Adenosine triphosphate—ABL1—nervous system—multiple sclerosis	0.000191	0.00179	CbGeAlD
Adenosine triphosphate—ABCC8—brain—multiple sclerosis	0.000188	0.00177	CbGeAlD
Adenosine triphosphate—ABL1—central nervous system—multiple sclerosis	0.000184	0.00173	CbGeAlD
Adenosine triphosphate—ABL1—cerebellum—multiple sclerosis	0.00018	0.00169	CbGeAlD
Adenosine triphosphate—AKT1—Azacitidine—Cladribine—multiple sclerosis	0.000148	0.0363	CbGdCrCtD
Adenosine triphosphate—ABL1—brain—multiple sclerosis	0.000146	0.00137	CbGeAlD
Adenosine triphosphate—HSPA1A—Azacitidine—Cladribine—multiple sclerosis	0.000126	0.0309	CbGdCrCtD
Adenosine triphosphate—ACVR1—Betamethasone—Methylprednisolone—multiple sclerosis	0.000111	0.0271	CbGdCrCtD
Adenosine triphosphate—ACVR1—Dexamethasone—Methylprednisolone—multiple sclerosis	0.000111	0.0271	CbGdCrCtD
Adenosine triphosphate—ABCB1—retina—multiple sclerosis	0.000109	0.00103	CbGeAlD
Adenosine triphosphate—ACVR1—Dexamethasone—Betamethasone—multiple sclerosis	0.000109	0.0267	CbGdCrCtD
Adenosine triphosphate—ACVR1—Betamethasone—Dexamethasone—multiple sclerosis	0.000109	0.0267	CbGdCrCtD
Adenosine triphosphate—ACVR1—Betamethasone—Triamcinolone—multiple sclerosis	0.000107	0.0261	CbGdCrCtD
Adenosine triphosphate—ACVR1—Dexamethasone—Triamcinolone—multiple sclerosis	0.000107	0.0261	CbGdCrCtD
Adenosine triphosphate—ACVR1—Dexamethasone—Prednisone—multiple sclerosis	0.000101	0.0247	CbGdCrCtD
Adenosine triphosphate—ACVR1—Betamethasone—Prednisone—multiple sclerosis	0.000101	0.0247	CbGdCrCtD
Adenosine triphosphate—ACVR1—Dexamethasone—Prednisolone—multiple sclerosis	9.88e-05	0.0241	CbGdCrCtD
Adenosine triphosphate—ACVR1—Betamethasone—Prednisolone—multiple sclerosis	9.88e-05	0.0241	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Flurandrenolide—Methylprednisolone—multiple sclerosis	9.53e-05	0.0233	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Flurandrenolide—Dexamethasone—multiple sclerosis	9.38e-05	0.0229	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Flurandrenolide—Betamethasone—multiple sclerosis	9.38e-05	0.0229	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Flurandrenolide—Prednisolone—multiple sclerosis	8.49e-05	0.0207	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Triamcinolone—Methylprednisolone—multiple sclerosis	7.92e-05	0.0194	CbGdCrCtD
Adenosine triphosphate—ABCB1—medulla oblongata—multiple sclerosis	7.91e-05	0.000742	CbGeAlD
Adenosine triphosphate—HSPA1A—Triamcinolone—Betamethasone—multiple sclerosis	7.79e-05	0.019	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Triamcinolone—Dexamethasone—multiple sclerosis	7.79e-05	0.019	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Fluticasone Propionate—Methylprednisolone—multiple sclerosis	7.72e-05	0.0189	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Fluticasone Propionate—Betamethasone—multiple sclerosis	7.6e-05	0.0186	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Fluticasone Propionate—Dexamethasone—multiple sclerosis	7.6e-05	0.0186	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Fluticasone Propionate—Triamcinolone—multiple sclerosis	7.43e-05	0.0181	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Diflorasone—Methylprednisolone—multiple sclerosis	7.3e-05	0.0178	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Fluocinolone Acetonide—Methylprednisolone—multiple sclerosis	7.28e-05	0.0178	CbGdCrCtD
Adenosine triphosphate—ABCB1—midbrain—multiple sclerosis	7.23e-05	0.000678	CbGeAlD
Adenosine triphosphate—HSPA1A—Triamcinolone—Prednisone—multiple sclerosis	7.23e-05	0.0177	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Diflorasone—Betamethasone—multiple sclerosis	7.18e-05	0.0176	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Diflorasone—Dexamethasone—multiple sclerosis	7.18e-05	0.0176	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Fluocinolone Acetonide—Betamethasone—multiple sclerosis	7.16e-05	0.0175	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Fluocinolone Acetonide—Dexamethasone—multiple sclerosis	7.16e-05	0.0175	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Triamcinolone—Prednisolone—multiple sclerosis	7.05e-05	0.0172	CbGdCrCtD
Adenosine triphosphate—ABCB1—spinal cord—multiple sclerosis	7.05e-05	0.000661	CbGeAlD
Adenosine triphosphate—HSPA1A—Diflorasone—Triamcinolone—multiple sclerosis	7.02e-05	0.0172	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Fluocinolone Acetonide—Triamcinolone—multiple sclerosis	7e-05	0.0171	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Diflorasone—Prednisone—multiple sclerosis	6.66e-05	0.0163	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Diflorasone—Prednisolone—multiple sclerosis	6.5e-05	0.0159	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Fluocinolone Acetonide—Prednisolone—multiple sclerosis	6.48e-05	0.0158	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Budesonide—Methylprednisolone—multiple sclerosis	6.4e-05	0.0156	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Budesonide—Betamethasone—multiple sclerosis	6.3e-05	0.0154	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Budesonide—Dexamethasone—multiple sclerosis	6.3e-05	0.0154	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Budesonide—Triamcinolone—multiple sclerosis	6.15e-05	0.015	CbGdCrCtD
Adenosine triphosphate—ABCB1—nervous system—multiple sclerosis	5.94e-05	0.000557	CbGeAlD
Adenosine triphosphate—HSPA1A—Budesonide—Prednisone—multiple sclerosis	5.84e-05	0.0143	CbGdCrCtD
Adenosine triphosphate—ABCB1—central nervous system—multiple sclerosis	5.72e-05	0.000537	CbGeAlD
Adenosine triphosphate—HSPA1A—Budesonide—Prednisolone—multiple sclerosis	5.7e-05	0.0139	CbGdCrCtD
Adenosine triphosphate—ABCB1—cerebellum—multiple sclerosis	5.59e-05	0.000524	CbGeAlD
Adenosine triphosphate—ABCB1—brain—multiple sclerosis	4.54e-05	0.000426	CbGeAlD
Adenosine triphosphate—HSPA1A—Dexamethasone—Methylprednisolone—multiple sclerosis	3.91e-05	0.00957	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Betamethasone—Methylprednisolone—multiple sclerosis	3.91e-05	0.00957	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Dexamethasone—Betamethasone—multiple sclerosis	3.85e-05	0.00941	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Betamethasone—Dexamethasone—multiple sclerosis	3.85e-05	0.00941	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Dexamethasone—Triamcinolone—multiple sclerosis	3.76e-05	0.0092	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Betamethasone—Triamcinolone—multiple sclerosis	3.76e-05	0.0092	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Betamethasone—Prednisone—multiple sclerosis	3.57e-05	0.00873	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Dexamethasone—Prednisone—multiple sclerosis	3.57e-05	0.00873	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Dexamethasone—Prednisolone—multiple sclerosis	3.49e-05	0.00852	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Betamethasone—Prednisolone—multiple sclerosis	3.49e-05	0.00852	CbGdCrCtD
Adenosine triphosphate—SLC25A4—Disease—TGFB1—multiple sclerosis	8.17e-06	5.63e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—GPCR downstream signaling—CCR5—multiple sclerosis	8.11e-06	5.59e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—CD86—multiple sclerosis	8.1e-06	5.58e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling by GPCR—TYK2—multiple sclerosis	8.1e-06	5.58e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—CD80—multiple sclerosis	8.09e-06	5.58e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Innate Immune System—MAPK1—multiple sclerosis	8.08e-06	5.57e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Innate Immune System—TYK2—multiple sclerosis	8.03e-06	5.53e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—SPP1—multiple sclerosis	8.02e-06	5.53e-05	CbGpPWpGaD
Adenosine triphosphate—SLC25A4—Disease—MAPK1—multiple sclerosis	8.01e-06	5.52e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—VCAM1—multiple sclerosis	8.01e-06	5.52e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—GPCR downstream signaling—IL2RA—multiple sclerosis	8e-06	5.51e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—HLA-DQA1—multiple sclerosis	7.99e-06	5.51e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—CCL5—multiple sclerosis	7.97e-06	5.5e-05	CbGpPWpGaD
Adenosine triphosphate—ACVR1B—Signaling Pathways—STAT3—multiple sclerosis	7.91e-06	5.45e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—HLA-DQB1—multiple sclerosis	7.88e-06	5.43e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Metabolism—BCHE—multiple sclerosis	7.87e-06	5.43e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—CCR5—multiple sclerosis	7.8e-06	5.38e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—CD86—multiple sclerosis	7.77e-06	5.35e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—GPCR downstream signaling—IL2—multiple sclerosis	7.74e-06	5.33e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—TYK2—multiple sclerosis	7.72e-06	5.32e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—IL2RA—multiple sclerosis	7.68e-06	5.3e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Axon guidance—MAPK1—multiple sclerosis	7.68e-06	5.3e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—CCL5—multiple sclerosis	7.65e-06	5.27e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Gene Expression—VDR—multiple sclerosis	7.61e-06	5.25e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—TYK2—multiple sclerosis	7.61e-06	5.24e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—CD86—multiple sclerosis	7.59e-06	5.23e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Metabolism—APOE—multiple sclerosis	7.49e-06	5.17e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—HLA-DQB1—multiple sclerosis	7.47e-06	5.15e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—CCL3—multiple sclerosis	7.47e-06	5.15e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—CD40LG—multiple sclerosis	7.44e-06	5.13e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—GPCR downstream signaling—IL2—multiple sclerosis	7.42e-06	5.11e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Hemostasis—IL2—multiple sclerosis	7.42e-06	5.11e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—TYK2—multiple sclerosis	7.4e-06	5.1e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—CYP24A1—multiple sclerosis	7.39e-06	5.1e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—CYP27B1—multiple sclerosis	7.39e-06	5.1e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—SPP1—multiple sclerosis	7.38e-06	5.09e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—CCR5—multiple sclerosis	7.37e-06	5.08e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—CD8A—multiple sclerosis	7.36e-06	5.07e-05	CbGpPWpGaD
Adenosine triphosphate—ACVR1B—Signaling Pathways—MYC—multiple sclerosis	7.35e-06	5.07e-05	CbGpPWpGaD
Adenosine triphosphate—ACVR1B—Signaling Pathways—TGFB1—multiple sclerosis	7.33e-06	5.05e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—IL2RA—multiple sclerosis	7.26e-06	5.01e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Innate Immune System—CD4—multiple sclerosis	7.26e-06	5e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—IFNG—multiple sclerosis	7.22e-06	4.98e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—CD86—multiple sclerosis	7.2e-06	4.96e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—PTGER4—multiple sclerosis	7.19e-06	4.96e-05	CbGpPWpGaD
Adenosine triphosphate—ACVR1B—Signaling Pathways—MAPK1—multiple sclerosis	7.19e-06	4.96e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—CCR5—multiple sclerosis	7.18e-06	4.95e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Developmental Biology—MMP9—multiple sclerosis	7.16e-06	4.93e-05	CbGpPWpGaD
Adenosine triphosphate—HSPA1B—Disease—IL6—multiple sclerosis	7.13e-06	4.92e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—TYK2—multiple sclerosis	7.12e-06	4.91e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—APOE—multiple sclerosis	7.09e-06	4.89e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—HLA-B—multiple sclerosis	7.08e-06	4.88e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—IL2RA—multiple sclerosis	7.08e-06	4.88e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—PGR—multiple sclerosis	7.08e-06	4.88e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—SPP1—multiple sclerosis	7.08e-06	4.88e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—CD40LG—multiple sclerosis	7.06e-06	4.86e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Hemostasis—IL2—multiple sclerosis	7.03e-06	4.85e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling by GPCR—IL2—multiple sclerosis	7.03e-06	4.84e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—CD86—multiple sclerosis	7.01e-06	4.83e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—CD8A—multiple sclerosis	6.98e-06	4.81e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—CD4—multiple sclerosis	6.98e-06	4.81e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Adaptive Immune System—CD4—multiple sclerosis	6.97e-06	4.8e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—CXCR3—multiple sclerosis	6.94e-06	4.79e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—IFNG—multiple sclerosis	6.93e-06	4.77e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—CCR5—multiple sclerosis	6.89e-06	4.75e-05	CbGpPWpGaD
Adenosine triphosphate—ABCC2—Transmembrane transport of small molecules—ALB—multiple sclerosis	6.89e-06	4.75e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by NGF—IL6—multiple sclerosis	6.88e-06	4.74e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—CD4—multiple sclerosis	6.88e-06	4.74e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—CD28—multiple sclerosis	6.88e-06	4.74e-05	CbGpPWpGaD
Adenosine triphosphate—ABCC8—Metabolism—APOE—multiple sclerosis	6.85e-06	4.72e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—TYK2—multiple sclerosis	6.83e-06	4.71e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—IL2RA—multiple sclerosis	6.79e-06	4.68e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Developmental Biology—MMP9—multiple sclerosis	6.78e-06	4.68e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—GPC5—multiple sclerosis	6.76e-06	4.66e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—CCR2—multiple sclerosis	6.75e-06	4.66e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling by GPCR—IL2—multiple sclerosis	6.74e-06	4.64e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—HLA-B—multiple sclerosis	6.71e-06	4.63e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—CD4—multiple sclerosis	6.69e-06	4.61e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—IL2RA—multiple sclerosis	6.63e-06	4.57e-05	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Disease—IL6—multiple sclerosis	6.58e-06	4.54e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—HLA-A—multiple sclerosis	6.56e-06	4.52e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—APOE—multiple sclerosis	6.54e-06	4.51e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Innate Immune System—IL6—multiple sclerosis	6.48e-06	4.47e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—IL1B—multiple sclerosis	6.44e-06	4.44e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—CD4—multiple sclerosis	6.44e-06	4.44e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Metabolism—POMC—multiple sclerosis	6.44e-06	4.44e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—IL2—multiple sclerosis	6.42e-06	4.43e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—CD80—multiple sclerosis	6.41e-06	4.42e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Developmental Biology—STAT3—multiple sclerosis	6.36e-06	4.39e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—GPCR downstream signaling—POMC—multiple sclerosis	6.34e-06	4.37e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—IL2RA—multiple sclerosis	6.29e-06	4.34e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—APOE—multiple sclerosis	6.27e-06	4.32e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—CNR1—multiple sclerosis	6.23e-06	4.3e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—HLA-A—multiple sclerosis	6.22e-06	4.29e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—CCR5—multiple sclerosis	6.22e-06	4.28e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Innate Immune System—IL6—multiple sclerosis	6.21e-06	4.28e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—IL1B—multiple sclerosis	6.18e-06	4.26e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—CD4—multiple sclerosis	6.18e-06	4.26e-05	CbGpPWpGaD
Adenosine triphosphate—SLC25A4—Disease—IL6—multiple sclerosis	6.16e-06	4.25e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—IL2—multiple sclerosis	6.16e-06	4.24e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—POMC—multiple sclerosis	6.09e-06	4.2e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—HLA-A—multiple sclerosis	6.06e-06	4.18e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Developmental Biology—STAT3—multiple sclerosis	6.03e-06	4.16e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—TLR4—multiple sclerosis	6e-06	4.14e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—HLA-DRB1—multiple sclerosis	5.99e-06	4.13e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—CCL2—multiple sclerosis	5.96e-06	4.11e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—CD80—multiple sclerosis	5.91e-06	4.07e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Axon guidance—IL6—multiple sclerosis	5.9e-06	4.07e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Developmental Biology—TGFB1—multiple sclerosis	5.9e-06	4.07e-05	CbGpPWpGaD
Adenosine triphosphate—ABCC8—Metabolism—POMC—multiple sclerosis	5.89e-06	4.06e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Metabolism—ALB—multiple sclerosis	5.87e-06	4.05e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Hemostasis—TGFB1—multiple sclerosis	5.79e-06	3.99e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Developmental Biology—MAPK1—multiple sclerosis	5.78e-06	3.99e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—POMC—multiple sclerosis	5.76e-06	3.97e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—ICAM1—multiple sclerosis	5.75e-06	3.97e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—TLR4—multiple sclerosis	5.69e-06	3.92e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—HLA-DRB1—multiple sclerosis	5.68e-06	3.92e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Hemostasis—MAPK1—multiple sclerosis	5.67e-06	3.91e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—CD80—multiple sclerosis	5.67e-06	3.91e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—APOE—multiple sclerosis	5.65e-06	3.9e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—CCL2—multiple sclerosis	5.63e-06	3.88e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—POMC—multiple sclerosis	5.61e-06	3.87e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—CXCL10—multiple sclerosis	5.61e-06	3.87e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—RRM1—multiple sclerosis	5.6e-06	3.86e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Developmental Biology—TGFB1—multiple sclerosis	5.59e-06	3.85e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—CD80—multiple sclerosis	5.54e-06	3.82e-05	CbGpPWpGaD
Adenosine triphosphate—ACVR1B—Signaling Pathways—IL6—multiple sclerosis	5.52e-06	3.81e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Developmental Biology—TNF—multiple sclerosis	5.51e-06	3.8e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—CCL2—multiple sclerosis	5.49e-06	3.79e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Hemostasis—TGFB1—multiple sclerosis	5.49e-06	3.78e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Developmental Biology—MAPK1—multiple sclerosis	5.48e-06	3.78e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—ICAM1—multiple sclerosis	5.45e-06	3.76e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB11—Metabolism—APOE—multiple sclerosis	5.42e-06	3.73e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—TYK2—multiple sclerosis	5.41e-06	3.73e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—STAT3—multiple sclerosis	5.4e-06	3.72e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—POMC—multiple sclerosis	5.38e-06	3.71e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Hemostasis—MAPK1—multiple sclerosis	5.38e-06	3.71e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling by GPCR—MAPK1—multiple sclerosis	5.37e-06	3.71e-05	CbGpPWpGaD
Adenosine triphosphate—ABCC8—Metabolism—ALB—multiple sclerosis	5.37e-06	3.7e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—CCL2—multiple sclerosis	5.27e-06	3.63e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—CD80—multiple sclerosis	5.25e-06	3.62e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Developmental Biology—TNF—multiple sclerosis	5.22e-06	3.6e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—STAT3—multiple sclerosis	5.18e-06	3.57e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	5.17e-06	3.56e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	5.16e-06	3.56e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling by GPCR—MAPK1—multiple sclerosis	5.15e-06	3.55e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—TYK2—multiple sclerosis	5.12e-06	3.53e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—CD80—multiple sclerosis	5.11e-06	3.52e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Innate Immune System—MAPK1—multiple sclerosis	5.11e-06	3.52e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	5.06e-06	3.49e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—TYK2—multiple sclerosis	4.99e-06	3.44e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—STAT3—multiple sclerosis	4.99e-06	3.44e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—MAPK1—multiple sclerosis	4.91e-06	3.39e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—CD86—multiple sclerosis	4.91e-06	3.38e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—MAPK1—multiple sclerosis	4.84e-06	3.34e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—CCL5—multiple sclerosis	4.83e-06	3.33e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	4.82e-06	3.32e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—TYK2—multiple sclerosis	4.78e-06	3.3e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—STAT3—multiple sclerosis	4.78e-06	3.3e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Metabolism—APOE—multiple sclerosis	4.74e-06	3.26e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—MAPK1—multiple sclerosis	4.71e-06	3.25e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—GPCR downstream signaling—IL2—multiple sclerosis	4.69e-06	3.23e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—TYK2—multiple sclerosis	4.67e-06	3.22e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB11—Metabolism—POMC—multiple sclerosis	4.65e-06	3.21e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—MYC—multiple sclerosis	4.63e-06	3.2e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—TGFB1—multiple sclerosis	4.62e-06	3.19e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—MAPK1—multiple sclerosis	4.53e-06	3.13e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—IL2—multiple sclerosis	4.51e-06	3.11e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—SPP1—multiple sclerosis	4.47e-06	3.08e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Developmental Biology—IL6—multiple sclerosis	4.44e-06	3.06e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—MYC—multiple sclerosis	4.44e-06	3.06e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—TGFB1—multiple sclerosis	4.43e-06	3.06e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—TYK2—multiple sclerosis	4.43e-06	3.05e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—IFNG—multiple sclerosis	4.38e-06	3.02e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—CCR5—multiple sclerosis	4.35e-06	3e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—MAPK1—multiple sclerosis	4.35e-06	3e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—TYK2—multiple sclerosis	4.32e-06	2.98e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—IL2RA—multiple sclerosis	4.29e-06	2.96e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—MMP9—multiple sclerosis	4.26e-06	2.94e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—IL2—multiple sclerosis	4.26e-06	2.93e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB11—Metabolism—ALB—multiple sclerosis	4.24e-06	2.93e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—CD4—multiple sclerosis	4.23e-06	2.91e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Developmental Biology—IL6—multiple sclerosis	4.21e-06	2.9e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—IL2—multiple sclerosis	4.15e-06	2.86e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—IFNG—multiple sclerosis	4.15e-06	2.86e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling by GPCR—IL6—multiple sclerosis	4.13e-06	2.85e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Metabolism—POMC—multiple sclerosis	4.07e-06	2.8e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—CD4—multiple sclerosis	4.01e-06	2.76e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—IL2—multiple sclerosis	3.98e-06	2.74e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—APOE—multiple sclerosis	3.96e-06	2.73e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling by GPCR—IL6—multiple sclerosis	3.96e-06	2.73e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—MMP9—multiple sclerosis	3.93e-06	2.71e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Innate Immune System—IL6—multiple sclerosis	3.93e-06	2.71e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—IL1B—multiple sclerosis	3.9e-06	2.69e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—CD4—multiple sclerosis	3.9e-06	2.69e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—IL2—multiple sclerosis	3.89e-06	2.68e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—STAT3—multiple sclerosis	3.79e-06	2.61e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—IL6—multiple sclerosis	3.77e-06	2.6e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—MMP9—multiple sclerosis	3.77e-06	2.6e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—IL6—multiple sclerosis	3.72e-06	2.57e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Metabolism—ALB—multiple sclerosis	3.71e-06	2.56e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—IL1B—multiple sclerosis	3.7e-06	2.55e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—IL2—multiple sclerosis	3.69e-06	2.54e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—IL6—multiple sclerosis	3.62e-06	2.49e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—CD80—multiple sclerosis	3.58e-06	2.47e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—MYC—multiple sclerosis	3.52e-06	2.43e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—TGFB1—multiple sclerosis	3.51e-06	2.42e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—STAT3—multiple sclerosis	3.49e-06	2.41e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—IL6—multiple sclerosis	3.48e-06	2.4e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—MAPK1—multiple sclerosis	3.45e-06	2.38e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—POMC—multiple sclerosis	3.4e-06	2.34e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—STAT3—multiple sclerosis	3.35e-06	2.31e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—IL6—multiple sclerosis	3.34e-06	2.3e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—CCL2—multiple sclerosis	3.33e-06	2.29e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—STAT3—multiple sclerosis	3.27e-06	2.26e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—MAPK1—multiple sclerosis	3.26e-06	2.24e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—MYC—multiple sclerosis	3.25e-06	2.24e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.24e-06	2.23e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—TGFB1—multiple sclerosis	3.24e-06	2.23e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—BCHE—multiple sclerosis	3.22e-06	2.22e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—MAPK1—multiple sclerosis	3.18e-06	2.19e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—MYC—multiple sclerosis	3.11e-06	2.15e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—TGFB1—multiple sclerosis	3.1e-06	2.14e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—STAT3—multiple sclerosis	3.1e-06	2.14e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—MAPK1—multiple sclerosis	3.04e-06	2.1e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Gene Expression—MYC—multiple sclerosis	3.02e-06	2.08e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—TYK2—multiple sclerosis	3.02e-06	2.08e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—STAT3—multiple sclerosis	3.02e-06	2.08e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—MAPK1—multiple sclerosis	2.98e-06	2.05e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—MAPK1—multiple sclerosis	2.82e-06	1.94e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—MYC—multiple sclerosis	2.81e-06	1.94e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—TGFB1—multiple sclerosis	2.8e-06	1.93e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—MAPK1—multiple sclerosis	2.75e-06	1.89e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—IL6—multiple sclerosis	2.65e-06	1.83e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—IL2—multiple sclerosis	2.51e-06	1.73e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—IL6—multiple sclerosis	2.5e-06	1.72e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—IL6—multiple sclerosis	2.44e-06	1.68e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—MMP9—multiple sclerosis	2.38e-06	1.64e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—IL6—multiple sclerosis	2.34e-06	1.61e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—IL6—multiple sclerosis	2.29e-06	1.58e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—IL6—multiple sclerosis	2.17e-06	1.49e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—STAT3—multiple sclerosis	2.12e-06	1.46e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—IL6—multiple sclerosis	2.11e-06	1.46e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—MYC—multiple sclerosis	1.97e-06	1.36e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—TGFB1—multiple sclerosis	1.96e-06	1.35e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—APOE—multiple sclerosis	1.94e-06	1.33e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—MAPK1—multiple sclerosis	1.92e-06	1.33e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—POMC—multiple sclerosis	1.66e-06	1.15e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—ALB—multiple sclerosis	1.52e-06	1.05e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—IL6—multiple sclerosis	1.48e-06	1.02e-05	CbGpPWpGaD
